Bioabsorbable Stents Industry Forecast to Hit $0.59 Billion by 2029 With a Strong 9.9% CAGR

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The Bioabsorbable Stents Market Size During 2025–2029?

The overall valuation of the bioabsorbable stents sector has experienced significant expansion lately; projecting forward, this market is anticipated to see its value climb from $0.37 billion in 2024 to reach $0.41 billion by 2025, reflecting a consistent compound annual growth rate of 9.2% during this forecast interval. This upward trajectory seen in the past can be linked to several key factors, including an increasing incidence of heart-related illnesses, a heightened need for surgical techniques that involve less intrusion, greater general knowledge regarding absorbable stent technology, growing levels of personal wealth, and substantial capital infusion from within the industry.

Projections indicate a robust expansion for the market encompassing bioabsorbable stents over the coming years, with its valuation anticipated to reach $0.59 billion by 2029, propelled by a compound annual growth rate (CAGR) of 9.9%; this upward trajectory during the forecast timeframe is fundamentally driven by broader clinical applications becoming available, the tailoring of products to individual needs, worldwide market penetration efforts, and the inherent advantages these devices offer to patients.Key developments shaping the industry throughout this forecast interval encompass progress in the development of bioabsorbable substances, breakthroughs in medical procedures, ongoing studies and published clinical evidence, the emergence of stent structures combining different technologies, the engineering of devices with extended dissolution timelines, and strategic alliances and cooperative ventures forged between entities.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3269&type=smp

What Are The Drivers Pushing New Developments In The Bioabsorbable Stents Market?

Elevated occurrences of cardiac insufficiency are anticipated to fuel the expansion within the market for bioabsorbable stents. This condition, known as heart failure, involves a diminished capacity of the heart muscle to effectively circulate blood, which subsequently leads to an undesirable buildup of excessive bodily fluids. The utilization of bioabsorbable stents offers a therapeutic avenue for addressing heart failure, aiming to improve cardiac function and alleviate associated clinical manifestations. As an illustration, data released in February 2022 by the Heart and Stroke Foundation of Canada, an established Canadian authority on stroke, cardiovascular ailments, necessary procedures, and therapies, indicated that 750,000 Canadians are presently living with a heart failure diagnosis, alongside an additional 100,000 new instances diagnosed each year for this chronic, untreatable ailment. Furthermore, forecasts suggest that by the year 2030, the yearly financial commitment within Canada for heart failure healthcare could climb to $2.8 billion, thereby cementing the rising incidence of heart failure as a key impetus for the future growth of the bioabsorbable stents market.

Which Key Segments Fueling The Bioabsorbable Stents Market?

The bioabsorbable stentsmarket covered in this report is segmented –

1) By Product Type: Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents

2) By Absorption Rate: Slow- Absorption Stents, Fast- Absorption Stents

3) By Applications: Coronary Artery Diseases, Peripheral Artery Diseases

Subsegments:

1) By Polymer-Based Bioabsorbable Stents: PLGA (Poly(Lactic-Co-Glycolic Acid)) Stents, PGA (Polyglycolic Acid) Stents, PLLA (Poly(L-Lactic Acid)) Stents, Other Biodegradable Polymer Stents

2) By Metal-Based Bioabsorbable Stents: Magnesium-Based Stents, Iron-Based Stents, Zinc-Based Stents, Other Metal-Based Bioabsorbable Stents

What Long-Term Trends Will Shape The Future Growth Of The Bioabsorbable Stents Industry?

Key players within the bioabsorbable stents sector are directing their efforts toward developing novel technologies, exemplified by the Next Generation of Bioresorbable Cardiac Stent, as a means to enhance their market earnings. This newer category of bioresorbable cardiac stents comprises sophisticated medical implants intended for managing coronary artery disease, constructed from materials capable of breaking down naturally once the vessel has been successfully scaffolded open. To illustrate this advancement, in July 2024, MicroPort Scientific Corporation, a manufacturer of medical equipment situated in China, secured official authorization from China’s National Medical Products Administration (NMPA) for what is globally recognized as the inaugural next-generation, completely absorbable cardiac stent. This device, conceptualized and engineered by MicroPort Scientific Corporation and known as Firesorb, is engineered to fully disintegrate within a three-year span, therefore substantially mitigating protracted risks like blood clotting. Data sourced from clinical evaluations involving 1,468 participants have demonstrated highly favorable outcomes, notably achieving a thrombosis incidence of merely 0.32% and a 4-year rate of target lesion failure standing at only 4.3%. Esteemed authorities in medicine have lauded its ground breaking thin-strut architecture and its excellence in covering the vessel lining when juxtaposed with earlier stent models.

Which Major Industry Participants Are Leading The Bioabsorbable Stents Market Growth?

Major companies operating in the bioabsorbable stents market include Abbott Laboratories, REVA Medical Inc., Elixir Medical Corporation, Biotronik SE & Co. KG, Amaranth Medical Inc., Zorion Medical Inc., Tepha Inc., S3V Vascular Technologies, ICON Interventional Systems Inc., Arterius Limited, Microport Scientific Corporation, Meril Life Sciences Pvt. Ltd., Medlogics Device Corporation, B. Braun Melsungen AG, Boston Scientific Corporation, C.R. Bard Inc., Stentys SA, Terumo Corporation, OrbusNeich, Arterial Remodeling Technologies, Cardionovum GmbH, Envision Scientific Pvt Ltd., Eurocor GmbH, Hexacath, Kyoto Medical Planning Co. Ltd., Lifetech Scientific (Shenzhen) Co. Ltd., Manli Cardiology Limited, Medtronic Inc., QualiMed Innovative Medizinprodukte GmbH, Sahajanand Medical Technologies Pvt. Ltd., Sinomed, Surmodics Inc., Translumina Therapeutics, Vascular Concepts Limited, Xenogenics Corporation

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report

What Are The Key Regional Factors Influencing The Bioabsorbable Stents Market Growth?

North America was the largest region in the bioabsorbable stents market in 2024. Western Europe was the second-largest region in the bioabsorbable stents market report. The regions covered in the bioabsorbable stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Request A Customized Version Of The Bioabsorbable Stents Market Report:

https://www.thebusinessresearchcompany.com/customise?id=3269&type=smp

Browse Through More Reports Similar to the Global Bioabsorbable Stents Market 2025, By The Business Research Company

Intracranial Stents Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/intracranial-stents-global-market-report

Bifurcation Lesions Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bifurcation-lesions-global-market-report

Peripheral Vascular Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/peripheral-vascular-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795